Surface Finish & Biocompatibility
A laser-cut edge is never directly implantable. The recast layer (re-solidified metal), HAZ, and oxidation products from cutting must be removed through post-processing to achieve a biocompatible surface that won't trigger adverse tissue reactions or accelerate corrosion in the body.
Quick Answer
The standard post-laser finishing sequence for implants: 1) Acid pickling (remove recast/slag), 2) Electropolishing (smooth surface to Ra < 0.4μm), 3) Passivation(rebuild protective oxide layer), 4) Final cleaning (ultrasonic + DI water rinse). The finished surface must pass ISO 10993 biocompatibility testing (2025 revision enhances risk-based approach) for the intended contact duration and type.
Post-Laser Finishing Sequence
| Step | Process | Purpose | Typical Ra After |
|---|---|---|---|
| 0. As-cut | — | Baseline (recast + HAZ present) | 1–5μm Ra |
| 1. Acid pickling | HF/HNO₃ immersion | Remove recast, oxides, slag | 0.5–2μm Ra |
| 2. Electropolishing | Anodic dissolution in electrolyte | Smooth surface, remove micro-burrs | 0.1–0.4μm Ra |
| 3. Passivation | Citric/nitric acid treatment | Form protective Cr₂O₃ or TiO₂ layer | Unchanged |
| 4. Final cleaning | Ultrasonic + DI water + dry | Remove all chemical residues | Unchanged |
Material-Specific Finishing
Stainless Steel (316LVM)
- • Electropolish: H₃PO₄/H₂SO₄ electrolyte, 40–60°C
- • Passivation: citric acid per ASTM A967
- • Target Ra: < 0.25μm for implant contact
- • Cr/Fe ratio > 1.5 verified by XPS
- • Blue passivation test per ASTM F1089
Nitinol
- • Critical: minimize Ni surface concentration
- • Shape-set before electropolish (preserve geometry)
- • Electropolish: methanol/HClO₄, −30°C to −40°C
- • Target: TiO₂-rich surface layer with Ni < 2 at%
- • Corrosion testing per ASTM F2129
Titanium (Ti-6Al-4V ELI)
- • Acid etch: HF/HNO₃ to remove alpha-case
- • No standard electropolishing (anodizing optional)
- • Micro-blasting for textured osseointegration surfaces
- • Target Ra depends on application (smooth vs textured)
- • Passivation per ASTM F86
CoCr Alloys (L-605)
- • Electropolish: H₃PO₄-based at 50–70°C
- • Very hard material — longer electropolish cycle
- • Target Ra: < 0.2μm for stent applications
- • Co ion release testing per ISO 10993-12
- • High corrosion resistance in body fluids
Related Topics
Disclaimer: Surface finishing for medical devices must be validated per FDA QMSR (incorporating ISO 13485:2016) requirements. Chemical formulations and parameters are reference starting points. Consult with your finishing supplier and regulatory team for device-specific protocols.